Boehringer Ingelheim Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
18 result(s) found, displaying 11 to 18
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Idarucizumab
-
Cancellation by sponsorRequested by Boehringer Ingelheim Pty Ltd
-
Cancellation by sponsorRequested by Boehringer Ingelheim Pty Ltd
-
Cancellation by sponsorRequested by Boehringer Ingelheim Pty Ltd
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Nintedanib esilate
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Dabigatran etexilate
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ACTILYSE alteplase (rch) 50 mg powder for injection vial with diluent vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ATROVENT UNIT DOSE VIALS ipratropium bromide 250 micrograms/1 mL (as monohydrate) conventional inhalation ampoule.